Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression

Autor: Kemp, D E, Ganocy, S J, Brecher, M, Carlson, B X, Edwards, S, Eudicone, J M, Evoniuk, G, Jansen, W, Leon, A C, Minkwitz, M, Pikalov, A, Stassen, H H, Szegedi, A, Tohen, M, Van Willigenburg, A P P, Calabrese, J R

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______885::28e5446e41ed9b95aaca0d4f4a0c7987
https://www.zora.uzh.ch/id/eprint/46882/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The impact of adjunctive aripiprazole on QT interval: A 12‐week open label study in patients on olanzapine, clozapine or risperidone.

Autor: Pilunthanakul, Thanita¹ (AUTHOR) thanita33@gmail.com, Ting, Mable Quek Jing¹ (AUTHOR), Lee, Jimmy^2,3 (AUTHOR), Gupta, Bhanu¹ (AUTHOR)

Publikováno v: Human Psychopharmacology: Clinical & Experimental. May2023, Vol. 38 Issue 3, p1-10. 10p.

Pharmacological and functional implications of developmentally-regulated changes in GABA~A receptor subunit expression in the cerebellum

Autor: Carlson, B. X., Elster, L., Schousboe, A.

Publikováno v: European Journal of Pharmacology; 1998, Vol. 352 Issue: 1 p1-14, 14p

Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy.

Autor: Espinola, Caroline W.^1,2 (AUTHOR), Khoo, Yuelee¹ (AUTHOR), Parmar, Roohie¹ (AUTHOR), Demchenko, Ilya¹ (AUTHOR), Frey, Benicio N.^3,4 (AUTHOR), Milev, Roumen V.⁵ (AUTHOR), Ravindran, Arun V.^2,6 (AUTHOR), Parikh, Sagar V.⁷ (AUTHOR), Ho, Keith¹ (AUTHOR), Rotzinger, Susan¹ (AUTHOR), Lou, Wendy⁸ (AUTHOR), Lam, Raymond W.⁹ (AUTHOR), Kennedy, Sidney H.^1,2,6,10 (AUTHOR), Bhat, Venkat^1,2,6,10 (AUTHOR) venkat.bhat@utoronto.ca

Publikováno v: Brain & Behavior. May2022, Vol. 12 Issue 5, p1-11. 11p.